Physician profile
Hugh E Berckmueller
NPI 1093701682
$2,222.03
in general payments reported to CMS, 2019-2025
20 companies · $289 in 2025
The $289 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $308 · 2020: $273 · 2021: $367 · 2022: $425 · 2023: $226 · 2024: $333 · 2025: $289.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $849.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $849.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bausch & Lomb Americas INC. | $310.13 | 2022-2025 | Miebo, Vyzulta, Lotemax Sm |
| Sun Pharmaceutical Industries INC. | $271.03 | 2019-2022 | |
| Allergan, INC. | $237.01 | 2019-2022 | |
| Alcon Vision LLC | $231.24 | 2021-2025 | Clareon, Rocklatan, Tryptyr |
| Tarsus Pharmaceuticals, INC. | $189.40 | 2024-2025 | Xdemvy |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $175.56 | 2019-2021 | |
| Kala Pharmaceuticals, INC. | $169.71 | 2019-2021 | |
| Novartis Pharmaceuticals Corporation | $169.44 | 2021-2023 | |
| Abbvie INC. | $134.46 | 2022-2024 | Durysta |
| Aerie Pharmaceuticals, INC. | $82.38 | 2019-2021 | |
| Mallinckrodt Hospital Products INC. | $47.85 | 2020-2024 | Acthar |
| Harrow Eye, LLC | $46.44 | 2024-2025 | Vevye |
| Rxsight INC | $30.11 | 2025 | Rxsight Light Delivery Device (Ldd), Rxsight Contact Lens, Rxsight Injector Handpiece |
| Oyster Point Pharma, INC. | $26.93 | 2023 | Tyrvaya |
| Dompe US, INC. | $23.27 | 2024 | Oxervate |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Johnson & Johnson Vision Care, INC. | $20.34 | 2019 | |
| Biotissue Holdings INC. | $16.99 | 2022 | |
| Thea Pharma INC. | $15.20 | 2025 | Iyuzeh |
| Shire North American Group INC | $14.54 | 2019 | |
| Oasis Medical, INC. | $10.00 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hugh Berckmueller listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.